19 completed. 19 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 19 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Mania: new trials by email Literature Review of Mania trials Research Report on Mania
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder RAP-219, Placebo - Bipolar 1 Disorder | Phase 2 | Completed | Rapport Therapeutics Inc. | 253 | 2025-07-25 | 2026-10-26 |
| BHV-7000 Acute Treatment of Bipolar Mania BHV-7000, Placebo - Bipolar Disorder | Phase 2 / Phase 3 | Completed | Biohaven Therapeutics Ltd. | 274 | 2024-05-28 | 2025-12-16 |
| Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania OMega 3, Placebo - Mania | Phase 2 | Completed | University of Cincinnati | 55 | 2009-06-01 | 2019-11-13 |
| Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania Cariprazine (RGH-188), Placebo - Bipolar Disorder | Phase 2 | Completed | Forest Laboratories | 238 | 2007-06-01 | 2017-04-14 |
| Effects of Pentazocine Versus Lorazepam on Manic Symptoms Pentazocine, Lorazepam - Bipolar Disorder, Schizoaffective Disorder | Phase 2 | Completed | Mclean Hospital | 19 | 2007-01-01 | 2019-03-06 |
| Lithium for the Treatment of Pediatric Mania Lithium Carbonate, Placebo - Bipolar I Disorder Without Psychotic Symptoms | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 61 | 2006-12-01 | 2012-02-28 |
| Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder MEM 1003 - Bipolar Disorder With Manic or Mixed Episodes | Phase 2 | Completed | Memory Pharmaceuticals | 60 | 2006-09-01 | 2008-05-06 |
| Open Label Trial of Acamprosate in Bipolar Alcoholics Acamprosate - Alcohol Dependence, Bipolar Disorder | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 9 | 2006-04-01 | 2008-09-19 |
| Effects of Pentazocine on Manic Symptoms Talwin Nx - Bipolar Disorder | Phase 2 | Completed | Mclean Hospital | 10 | 2005-09-01 | 2014-09-04 |
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study taurine - Bipolar Disorder, Mania | Phase 2 | Completed | Mclean Hospital | 60 | 2005-04-01 | 2019-03-01 |
| An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder Memantine HCl - Bipolar Disorder | Phase 2 | Completed | Forest Laboratories | 35 | 2005-02-01 | 2012-03-05 |
| Cytidine and Omega-3 Fatty Acids in Bipolar Disorder cytidine, omega-3 fatty acids, placebo - Bipolar Disorder | Phase 2 | Completed | Mclean Hospital | 90 | 2004-07-01 | 2012-04-20 |
| Escitalopram as a Mood Stabilizer for Bipolar II Disorder Escitalopram (Lexapro) - Bipolar Disorders | Phase 2 | Completed | The University of New South Wales | 10 | 2004-02-01 | 2006-01-02 |
| Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? Tamoxifen, Progesterone, placebo - Bipolar Disorder, Mania | Phase 2 | Completed | The Alfred | 51 | 2004-01-01 | 2008-10-24 |
| Clozapine for Treatment-Resistant Mania Clozapine - Bipolar Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 42 | 2002-01-01 | 2008-03-04 |
| Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder Tamoxifen - Bipolar Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 50 | 2001-11-09 | 2017-07-02 |
| Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness levetiracetam - Bipolar Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 30 | 2001-04-01 | 2008-03-04 |
| Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders Magstim Super Rapid Magnetic Stimulator, Cadwell MES-10 - Bipolar Disorder, Mood Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 91 | 1996-05-01 | 2006-07-13 |
| New Drugs in the Treatment of Mood Disorders Lamotrigine (Lamictal® (Registered Trademark), Gabapentin (Neurontin® (Registered Trademark)) - Anxiety Disorder, Mood Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 60 | 1995-05-01 | 2008-03-04 |
Bipolar Disorder (15) · Depression (7) · Mood Disorders (3) · Psychotic Disorders (3) · Alcoholism (1) · Anxiety Disorders (1) · Behavior, Addictive (1) · Depressive Disorder (1) · Impulsive Behavior (1) · Substance-Related Disorders (1)
Nervous System Diseases (19) · Neurobehavioral Manifestations (19) · Neurologic Manifestations (19) · Pathological Conditions, Signs and Symptoms (19) · Signs and Symptoms (19) · Bipolar and Related Disorders (15) · Mental Disorders (15) · Mood Disorders (12) · Behavior (7) · Behavioral Symptoms (7) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Alcohol-Related Disorders (1) · Chemically-Induced Disorders (1) · Compulsive Behavior (1)
Pentazocine (2) · Tamoxifen (2) · talwin Nx (2) · Acamprosate (1) · Clozapine (1) · Cytidine (1) · Docosahexaenoic Acids (1) · Escitalopram (1) · Fatty Acids, Omega-3 (1) · Fish Oils (1) · Gabapentin (1) · Lamotrigine (1) · Levetiracetam (1) · Lithium Carbonate (1) · Lorazepam (1)
National Institute of Mental Health (NIMH) (5) · Mclean Hospital (4) · Forest Laboratories (2) · Biohaven Therapeutics Ltd. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Medical University of South Carolina (1) · Memory Pharmaceuticals (1) · Rapport Therapeutics Inc. (1) · The Alfred (1) · The University of New South Wales (1) · University of Cincinnati (1)
United States (16) · Australia (2)
Beth L Murphy, MD, PhD (3) · Beth L Murphy, MD/PhD (1) · Bryan K. Tolliver, M.D., Ph.D. (1) · Edwin A Gomez, MD (1) · Gordon Parker (1) · Jayashri Kulkarni, MBBS, MPM, FRANZCP, PhD (1) · Kathleen T. Brady, M.D., Ph.D. (1) · Melissa DelBello, MD (1) · Robert L Findling, MD (1) · Robert McNamara, PhD (1) · Stephen R Murray, MD, PhD (1)
PMID 17897484, PMID 18700004, PMID 22926607, PMID 29017067, PMID 30738555, PMID 31344528
K24DA000435 (1)